135 related articles for article (PubMed ID: 31334835)
1. Safety of systemic therapies in the treatment of psoriasis with concomitant cirrhosis: a retrospective study.
Blaszczak AM; Dunaway S; Ali Alikhan M; Kelly S; Levin D; Kaffenberger J
Int J Dermatol; 2019 Nov; 58(11):e228-e229. PubMed ID: 31334835
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases.
Begon E; Beneton N; Poiraud C; Droitcourt C; Jacobzone C; Vermersch-Langlin A; Descamps V; Perrot JL; Khemis A; Pallure V; Fougerousse AC; Sigal-Grinberg M; Schmutz JL; Goujon C; Reguiai Z;
Br J Dermatol; 2018 Aug; 179(2):512-513. PubMed ID: 29480522
[No Abstract] [Full Text] [Related]
3. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
[No Abstract] [Full Text] [Related]
4. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
Gkini MA; Bewley AP
Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
[No Abstract] [Full Text] [Related]
5. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection.
Piaserico S; Conti A; Coati I; Galdo G; Bernabucci V; Zanca A; Drabeni M; Masutti F; Musumeci ML; Alberti A; Russo FP
G Ital Dermatol Venereol; 2019 Jun; 154(3):376-377. PubMed ID: 28712266
[No Abstract] [Full Text] [Related]
6. Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies.
Watson N; Wu K; Farr P; Reynolds NJ; Hampton PJ
Br J Dermatol; 2019 Jan; 180(1):195-196. PubMed ID: 30101563
[No Abstract] [Full Text] [Related]
7. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
[No Abstract] [Full Text] [Related]
8. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.
Bardazzi F; Magnano M; Campanati A; Loconsole F; Carpentieri A; Potenza C; Bernardini N; Di Lernia V; Carrera C; Raone B; Patrizi A; Loi C
Acta Derm Venereol; 2017 Aug; 97(8):989-990. PubMed ID: 28512671
[No Abstract] [Full Text] [Related]
9. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
[TBL] [Abstract][Full Text] [Related]
10. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
Leonardi CL
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
[TBL] [Abstract][Full Text] [Related]
11. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
12. Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab.
Nakahara T; Konishi S; Yasukochi Y; Esaki H; Tsuji G; Kido-Nakahara M; Furue M
J Dermatol; 2019 May; 46(5):e157-e158. PubMed ID: 30353917
[No Abstract] [Full Text] [Related]
13. Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
Philippe L; Badie J; Faller JP; Krattinger É; Deconinck E; Aubin F
Acta Derm Venereol; 2015 Apr; 95(4):495-6. PubMed ID: 25325260
[No Abstract] [Full Text] [Related]
14. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
15. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
[TBL] [Abstract][Full Text] [Related]
16. Association between clinical factors and dose modification strategies in the treatment with ustekinumab for moderate-to-severe plaque psoriasis.
Romero-Jimenez RM; Escudero-Vilaplana V; Baniandres Rodriguez O; García Martín E; Mateos Mayo A; Sanjurjo Saez M
J Dermatolog Treat; 2018 Dec; 29(8):792-796. PubMed ID: 29676189
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.
Langley RG; Lebwohl M; Krueger GG; Szapary PO; Wasfi Y; Chan D; Hsu MC; You Y; Poulin Y; Korman N; Prinz JC; Reich K;
Br J Dermatol; 2015; 172(5):1371-83. PubMed ID: 25307931
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Gordon KB; Strober B; Lebwohl M; Augustin M; Blauvelt A; Poulin Y; Papp KA; Sofen H; Puig L; Foley P; Ohtsuki M; Flack M; Geng Z; Gu Y; Valdes JM; Thompson EHZ; Bachelez H
Lancet; 2018 Aug; 392(10148):650-661. PubMed ID: 30097359
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials.
McMichael A; Desai SR; Qureshi A; Rastogi S; Alexis AF
Am J Clin Dermatol; 2019 Apr; 20(2):267-276. PubMed ID: 30471012
[TBL] [Abstract][Full Text] [Related]
20. An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice.
Salgüero Fernández I; Gil MH; Sanz MS; Gullón GR
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):244-246. PubMed ID: 29961546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
